Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 19054 | 457 | 34.7 | 65% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 332 | 17329 | COMPLEMENT//MANNOSE BINDING LECTIN//PAROXYSMAL NOCTURNAL HEMOGLOBINURIA |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ACUTE MYOCARDIAL DISEASE | Author keyword | 1 | 100% | 0% | 2 |
| 2 | THANATOCHEMISTRY | Author keyword | 1 | 50% | 0% | 2 |
| 3 | COMPLEMENT C9 | Author keyword | 1 | 33% | 1% | 3 |
| 4 | CONTRACTION BAND NECROSIS | Author keyword | 1 | 16% | 1% | 6 |
| 5 | CONTRACTION BANDS | Author keyword | 1 | 33% | 0% | 2 |
| 6 | ADRENERGIC STRESS | Author keyword | 1 | 50% | 0% | 1 |
| 7 | ANESTHESIABRIGHAM WOMENS HOSP | Address | 1 | 50% | 0% | 1 |
| 8 | ANTI C5A ANTIBODY | Author keyword | 1 | 50% | 0% | 1 |
| 9 | ANTIGENS CD59 | Author keyword | 1 | 50% | 0% | 1 |
| 10 | C5 BLOCKADE | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ACUTE MYOCARDIAL DISEASE | 1 | 100% | 0% | 2 | Search ACUTE+MYOCARDIAL+DISEASE | Search ACUTE+MYOCARDIAL+DISEASE |
| 2 | THANATOCHEMISTRY | 1 | 50% | 0% | 2 | Search THANATOCHEMISTRY | Search THANATOCHEMISTRY |
| 3 | COMPLEMENT C9 | 1 | 33% | 1% | 3 | Search COMPLEMENT+C9 | Search COMPLEMENT+C9 |
| 4 | CONTRACTION BAND NECROSIS | 1 | 16% | 1% | 6 | Search CONTRACTION+BAND+NECROSIS | Search CONTRACTION+BAND+NECROSIS |
| 5 | CONTRACTION BANDS | 1 | 33% | 0% | 2 | Search CONTRACTION+BANDS | Search CONTRACTION+BANDS |
| 6 | ADRENERGIC STRESS | 1 | 50% | 0% | 1 | Search ADRENERGIC+STRESS | Search ADRENERGIC+STRESS |
| 7 | ANTI C5A ANTIBODY | 1 | 50% | 0% | 1 | Search ANTI+C5A+ANTIBODY | Search ANTI+C5A+ANTIBODY |
| 8 | ANTIGENS CD59 | 1 | 50% | 0% | 1 | Search ANTIGENS++CD59 | Search ANTIGENS++CD59 |
| 9 | C5 BLOCKADE | 1 | 50% | 0% | 1 | Search C5+BLOCKADE | Search C5+BLOCKADE |
| 10 | CANINE VENTRICLE | 1 | 50% | 0% | 1 | Search CANINE+VENTRICLE | Search CANINE+VENTRICLE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BABOON MYOCARDIUM | 19 | 80% | 3% | 12 |
| 2 | ISCHEMIC HYPOXIC DAMAGE | 12 | 86% | 1% | 6 |
| 3 | HEART SUBCELLULAR MEMBRANES | 5 | 55% | 1% | 6 |
| 4 | CARDIAC LYMPH | 4 | 38% | 2% | 8 |
| 5 | INFARCTED AREAS | 3 | 50% | 1% | 5 |
| 6 | HUMAN C1Q | 3 | 31% | 2% | 9 |
| 7 | RABBIT ISOLATED HEART | 2 | 44% | 1% | 4 |
| 8 | MYOFIBRILLAR DEGENERATION | 2 | 67% | 0% | 2 |
| 9 | PEXELIZUMAB REDUCES DEATH | 2 | 67% | 0% | 2 |
| 10 | ANTI CD18 ANTIBODY | 2 | 30% | 1% | 6 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Role of complement and perspectives for intervention in ischemia-reperfusion damage | 2012 | 20 | 101 | 17% |
| The role of neutrophils in myocardial ischemia-reperfusion injury | 1999 | 370 | 164 | 13% |
| Leukocyte and endothelial adhesion molecule studies in knockout mice | 2004 | 52 | 24 | 29% |
| Role of complement factors and their inhibitors in the myocardial infarction | 2013 | 0 | 11 | 55% |
| A vital role for complement in heart disease | 2014 | 3 | 108 | 13% |
| Complement activation in heart diseases: Role of oxidants | 2000 | 39 | 69 | 23% |
| Complement inhibition by anti-C5 antibodies - from bench to bedside and back again | 2007 | 5 | 26 | 35% |
| POSTREPERFUSION INFLAMMATION - A MODEL FOR REACTION TO INJURY IN CARDIOVASCULAR-DISEASE | 1994 | 182 | 80 | 19% |
| Oxidative stress and neutrophil activation - the two keystones of ischemia/reperfusion injury | 2002 | 160 | 183 | 9% |
| Complement and its implications in cardiac ischemia/reperfusion: strategies to inhibit complement | 2001 | 22 | 101 | 31% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ANESTHESIABRIGHAM WOMENS HOSP | 1 | 50% | 0.2% | 1 |
| 2 | CARDIOVASC THORAC SURG CVTS | 1 | 50% | 0.2% | 1 |
| 3 | HEART VALVE GRP | 1 | 50% | 0.2% | 1 |
| 4 | MED DIABETES ENDOCRINOL M | 1 | 50% | 0.2% | 1 |
| 5 | MED INTERNAL MED 1 CHUO KU | 1 | 50% | 0.2% | 1 |
| 6 | KAISER PERMANENTE MED | 1 | 20% | 0.7% | 3 |
| 7 | INTERNAL MED B CLIN IMMUNOL | 0 | 33% | 0.2% | 1 |
| 8 | MAYO PHYSICIAN ALLIANCE CLIN TRIALS | 0 | 33% | 0.2% | 1 |
| 9 | DE BAKEY HEART | 0 | 25% | 0.2% | 1 |
| 10 | SPEROS P MARTEL | 0 | 25% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000135342 | ACYLATION STIMULATING PROTEIN//C3ADESARG//MIKE ROSENBLOOM CARDIOVASC |
| 2 | 0.0000131648 | AURAMINE STAINING//ROMANOWSKY STAIN//NEGATIVE IMAGES |
| 3 | 0.0000113368 | ALPHA TOCOPHEROL ANALOG//MYOCARDIAL STUNNING//CORONARY ARTERY REPERFUSION |
| 4 | 0.0000113138 | C5A//C5A RECEPTOR//C5AR |
| 5 | 0.0000094725 | WOUND AGE//WOUND AGE DETERMINATION//FORENSIC MOLECULAR PATHOLOGY |
| 6 | 0.0000083928 | COMPSTATIN//COBRA VENOM FACTOR//STELLAR CHANCE S 401 |
| 7 | 0.0000080471 | CD59//CRRY//CD55 |
| 8 | 0.0000079087 | COMPLEMENT SYNTHESIS//MRC TRANSPLANTAT TRANSPLANTAT IMMUNOL M//COMPLEMENTO |
| 9 | 0.0000076100 | HYPOXIC HEART DAMAGE//EHF DIELECTROMETRY//NO FLOW PHENOMENON |
| 10 | 0.0000070356 | CARDIOPULMONARY BYPASS//PERFUSION-UK//MODIFIED ULTRAFILTRATION |